Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore!   Learn More →
← Back to all trials
Completed NCT05456750

the Investigation of Therapeutic Effect After ILIB for Ischemic Stroke Patient

Conditions: Ischemic Stroke

Sex: All
Ages: 20 Years – 80 Years
Healthy volunteers: No
Phase: NA
Enrollment: 22
Sponsor: Tri-Service General Hospital

Location: Tri-service general hospital Taipei

Summary

The aim of our study is to therapeutic effect after intravenous laser irradiation of blood for ischemic stroke patient

Eligibility Criteria

Inclusion Criteria: * Aged between 20 to 80 years old * Able to speak and understand Mandarin/Taiwanese * No cognitive impairment * Residual motor function impairment (mRS\>1) * Mild stroke (NIHSS=1-4) or Moderate stroke(NIHSS=5-15) * No psychological disease Exclusion Criteria: * Severe stroke (NIHSS=16-42) * History of intracerebral hemorrhage and other major surgery * History of malignancy, chronic kidney disease * Active infection * Chronic hepatitis B or Chronic hepatitis C * Unstable angina or acute myocardial infarction within 6 months * Severe cognition impairment * Pregnancy

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT05456750). StuddyBuddy aggregates publicly available trial information.